Certified by Founder Lodge
Alpha-9 Oncology
United States - Boston, Massachusetts
START UP
1 Disclosed Funding Rounds $175,000,000
0 Participating Investments
-
Founded date
2018
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Alpha-9 Oncology is a clinical stage, radiopharmaceutical company developing differentiated and highly targeted radiopharmaceuticals with the potential to meaningfully improve the treatment o
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| October, 24 ,2024 | Series C | $175,000,000 |
Digitalis Ventures
Nextech Invest
Janus Henderson Investors
Longitude Capital
Lumira Ventures
Samsara BioCapital
Ascenta Capital
Frazier Life Sciences
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Valinor | $13,000,000 | (Dec 12, 2025)
Double (1) | $6,500,000 | (Dec 12, 2025)
Keeper | $4,000,000 | (Dec 12, 2025)
OnCorps AI | $55,000,000 | (Dec 12, 2025)
Cyphlens | $3,800,000 | (Dec 12, 2025)
